Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. The report includes detailed competitive landscape of the global nonalcoholic steatohepatitis market and an analysis of Porter’s five forces model for the NASH market has also been included.

1. Published By: Syndicate Market Research
Nonalcoholic Steatohepatitis Market - Global
Industry Perspective, Comprehensive Analysis
and Forecast, 2014 – 2020
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach,
Florida 33442, USA
Tel: +1-386-310-3803
Toll Free: 1-855-465-4651
sales@SyndicateMarketResearch.com
http://www.syndicatemarketresearch.com/

2. Nonalcoholic Steatohepatitis Market
sales@SyndicateMarketResearch.com
Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It
is also known as silent liver disease. It is a type of nonalcoholic fatty liver disease (NAFLD), which mainly
affects people with diabetes and obesity. Nonalcoholic Steatohepatitis (NASH) is defined by histological
hallmarks of inflammation, hepatic steatosis, cell death, and fibrosis. A number of drugs used to treat medical
situation have been NASH, such as amiodarone (Corderone, Pacerone), tamoxifen (Nolvadex), perhexiline
maleate (Pexhid) and steroids (eg, prednisone). Medical studies have identified a strong connection of NASH
with certain risk factors such as insulin resistance, oxidative stress and release of toxic inflammatory proteins.
Nonalcoholic steatohepatitis is a gradually becoming common chronic liver disease around the world and is
closely related with diabetes and obesity. Rising incidence of NAFLD cases, changing lifestyle patterns,
increasing rate of obesity and diabetes, and initiatives for research and development are the major driving
factors of this market. However, insufficient information about the pathophysiology of NASH tissue and
ineffective diagnostic technology for NASH is considered to restraint in this market.
Get Full Detail @ http://www.syndicatemarketresearch.com/market-
analysis/nonalcoholic-steatohepatitis-market.html
The report includes detailed competitive landscape of the global nonalcoholic steatohepatitis market and an
analysis of Porter’s five forces model for the nonalcoholic steatohepatitis market has also been included. It
includes company market share analysis, product portfolio of the major industry participants. The report

3. Nonalcoholic Steatohepatitis Market
sales@SyndicateMarketResearch.com
provides detailed segmentation of the nonalcoholic steatohepatitis market based on drugs type and region
segment. GFT505, Obeticholic Acid (INT-747), Simtuzumab and Liraglutide (Victoza), Vitamin E, Poglitazone,
Placebo is the drug type segment of nonalcoholic steatohepatitis market.
Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America,
and Middle East and Africa with its further bifurcation into major countries including U.S., Germany, France,
UK, China, Japan, India, and Brazil. This segmentation includes demand for nonalcoholic steatohepatitis
based on individual products and applications in all the regions and countries. The nonalcoholic steatohepatitis
market is dominated by North America followed by Asia Pacific. Asia pacific is expected to the fastest growing
segment in the forecast period.
Get Request Sample @ http://www.syndicatemarketresearch.com/request-for-
sample.html?flag=S&repid=52719
The report covers detailed competitive outlook including company profiles of the key participants operating in
the global market. Key players profiled in the report include Intercepts Pharmaceuticals, Exalenz Bioscience
Inc., Galectin Therapeutics Inc., Genfit, Gilead Science, AstraZeneca plc, Echosense SA, Raptor
Pharmaceutical Corp, Matinas Biopharma Holdings Inc., Enzo Biochem, Inc., Galmed Pharmaceuticals Ltd.,
Perspectum Diagnostics and Novo Nordisk.
This report segments the global nonalcoholic steatohepatitis market as follows:
Global Nonalcoholic Steatohepatitis Market: Drug Type Segment Analysis

4. Nonalcoholic Steatohepatitis Market
sales@SyndicateMarketResearch.com
 GFT505
 Obeticholic Acid (INT-747)
 Simtuzumab and Liraglutide (Victoza)
 Vitamin E
 Poglitazone
 Placebo
Global Nonalcoholic Steatohepatitis Market: Regional Segment Analysis
 North America
o U.S.
 Europe
o UK
o France
o Germany
 Asia Pacific
o China
o Japan
o India
 Latin America
o Brazil
 Middle East And Africa

5. Nonalcoholic Steatohepatitis Market
sales@SyndicateMarketResearch.com
Browse the “Nonalcoholic Steatohepatitis Market - Global Industry Perspective,
Comprehensive Analysis and Forecast, 2014 – 2020@
http://www.syndicatemarketresearch.com/market-analysis/nonalcoholic-
steatohepatitis-market.html
Syndicate market research
Address: Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442, USA
Tel: +1-386-310-3803 Tel: +1-855-465-4651 (US/CAN TOLL
FREE)
Email: sales@SyndicateMarketResearch.com Web:http://www.syndicatemarketresearch.com/